# Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster

> **NCT07672626** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1200 (actual)

## Conditions studied

- Vaccine

## Interventions

- **BIOLOGICAL:** the tested vaccine
- **BIOLOGICAL:** the control vaccine

## Key facts

- **NCT ID:** NCT07672626
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-19
- **Primary completion:** 2024-08-26
- **Final completion:** 2024-12-16
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672626, "Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07672626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*